Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPhase 3 trial protocol: weekly titration from 1mg to 12mg. Triple GLP-1/GIP/Glucagon agonist with up to 24% weight loss in clinical trials.
Appetite suppression begins within 3–5 days in most users. Hunger reduction noticeable even at 1 mg for many, though highly variable between individuals.
Measurable weight loss. Most users report 1–1.5 lbs/week. Cravings and food noise significantly reduced. Energy improving alongside early weight loss.
Strong weight loss continues. Many users report 1.5–2.5 lbs/week. This range is commonly described as the "sweet spot" — high efficacy with manageable tolerability.
For educational purposes only. Not medical advice. Consult a healthcare provider before starting any peptide protocol.